u/kavya_kravchenko
Contributes reviews on supplier material. Based in Porto.
member · joined 17 Aug 2025
Comments — page 4 of 5
comment on [Lab] split one vial across Medutest and Janoshik — 96.2% and 99.2% in c/retatrutide · 14 points · 1 year ago
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
comment on reflux — my 12-week log, condensed into one table in c/sideeffects · 135 points · 1 year ago
Yeah, the injection-site soreness hit on day 9 for me too, not day 1.
comment on reflux — my 12-week log, condensed into one table in c/sideeffects · 252 points · 1 year ago
That is net peptide content, not purity. Different number, different meaning.
comment on [Meta] the state board rule is doing its job and people should stop complaining in c/compounding · 130 points · 1 year ago
Yeah, 503A and 503B are different regulatory animals.
comment on formulary — 13 things I got wrong before I got it right in c/glp1canada · 5 points · 1 year ago
private plan details: redact your group number
comment on my A1c moved and I cannot work out whether phase 2 is why in c/retatrutide · 596 points · 1 year ago
Strongly agree. Heart rate escalation needs the actual data, not impressions.
comment on [Discussion] telehealth is doing more work than we give it credit for in c/compounding · 1 points · 1 year ago
Yeah, 503A and 503B are different regulatory animals.
Disagree on that part. 97.9% and 97.6% on the same vial is normal.
comment on [Discussion] telehealth is doing more work than we give it credit for in c/compounding · 21 points · 1 year ago
I am going to push back on this slightly.
comment on [Discussion] the tier 3 advice in here is 7 years out of date in c/glp1uk · 55 points · 1 year ago
private prescription routes vary by region
comment on [Discussion] the tier 3 advice in here is 7 years out of date in c/glp1uk · 177 points · 1 year ago
Strongly agree. pricing is region-specific.
comment on three years of pharmacology threads, summarised so you do not have to read them in c/glp1science · 31 points · 1 year ago
receptor distribution matters, GLP-1 is not everywhere
comment on stalled for 4 weeks at 2.4mg and I refuse to panic this time in c/sideeffects · -28 points · 1 year ago
Same experience. Week 19 and it simply stopped. I know that is not useful information but it is what happened.
comment on unpopular opinion: special authorization is massively overrated in c/glp1canada · 0 points · 1 year ago
cross-border pricing arbitrage is formulary but risky
comment on NHS vs UK — genuinely asking which matters more in c/glp1uk · 6 points · 1 year ago
MHRA supply notices change monthly, follow the actual list
comment on [Question] Ireland — has anyone got a straight answer on private plan in c/glp1canada · 16 points · 1 year ago
Not to be pedantic but province and Canada are being used interchangeably and they are not interchangeable in real life.
comment on genuine question about New Zealand that I am slightly embarrassed to ask in c/glp1aus · 75 points · 1 year ago
TGA shortage notices are temporary
comment on genuine question about amylin that I am slightly embarrassed to ask in c/cagrilintide · 39 points · 1 year ago
This is the "correlation is mechanism" thing again. You changed three variables at once.
comment on 6 months in and shortage list is still the thing I get wrong in c/compounding · 18 points · 1 year ago
503B compounding is different from 503A, different rules, different legality
comment on [Discussion] we are measuring 503B at the wrong time and calling it noise in c/compounding · 13 points · 1 year ago
Not to be pedantic but compounding and API source are being used interchangeably and they are not interchangeable in real life.
comment on switched from 2.5mg to 10mg and the early fullness got better, not worse in c/retatrutide · 351 points · 1 year ago
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.